Features
Advances in Retinal Biomarkers and Retinal Tracers
Investigational tracers could streamline diagnosis of retinal and systemic disease.
By Susan L. Worley, contributing writer
Artificial Intelligence and Augmented Intelligence in Ophthalmic Practice
New technologies enhance patient experiences and maximize the ability of ophthalmologists to practice effectively.
By Miguel A. Busquets, MD, FACS, FASRS
Retinal Fluid Fluctuations in the Treatment of Neovascular AMD
Control of fluid could optimize outcomes.
By Veeral S. Sheth, MD, MBA, FACS, Rhianon Reynolds, MD
Interpreting OCT Images Showing Pisciform Fundus Flecks
An imaging challenge recap explores diagnosis for flecks in the posterior pole.
By Marianeli Rodriguez, MD, PhD
The Past, Present, and Future of Private Equity in Retina
Retina specialists can enjoy the benefits at any career stage.
By David F. Williams, MD, MBA
Noninsulin Diabetes Medication and Diabetic Retinopathy
Medications can cause worsening of DR at initiation of treatment.
By Lakshman Mulpuri, MD, Jayanth Sridhar, MD
Departments
UPFRONT: Artificial Intelligence and Imaging in Retinal Surgery
By Peter K. Kaiser, MD
CONTROVERSIES IN CARE: Macular Atrophy Associated With Anti-VEGF Therapy for Wet AMD
Retina specialists discuss what might be an inconvenient truth.
By Michael Colucciello, MD, Jayanth Sridhar, MD, Anton Kolomeyer, MD, PhD
CLINICAL TRIAL DOWNLOAD: High-dose Aflibercept for Wet AMD and DME
Investigators discuss results from 2 phase 3 studies.
By Yasha Modi, MD , PAOLO LANZETTA, MD, David Brown, MD
CODING Q&A: Intravitreal Medications for Geographic Atrophy
Billing questions will arise with new drug treatment.
By Suzanne L. Corcoran, COE
UVEITIS CORNER: Multimodal Imaging in Infectious Retinitis
Characteristic findings can help distinguish etiologies.
By Sruthi Arepalli, MD, Chandni Duphare, MD, Arthi Venkat, MD, MS
NEW PRODUCT APPLICATIONS: Updates to the Stellaris Elite System
Upgrades improve the system's efficiency during vitreoretinal surgery.
By Karen Appold, contributing writer
News
SUBSPECIALTY NEWS: Progress toward GA drug approval, new gene therapy data, and more.
By Rochelle Nataloni, contributing writer